Latest GeoVax News
Archive Switch to Calendar view
- GeoVax Awarded $2.4 Million from U.S. Department of Defense to Advance Lassa Fever Vaccine
- GeoVax Comments on Age-Associated HIV Infection Trends in the U.S.
- GeoVax Comments on Recent Vaccine Development Study Funded by the Gates Foundation
- GeoVax to Report Vaccine Development Progress at the 12th Vaccine Congress in Budapest
- GeoVax Strengthens Scientific Staff and Expertise